Tag: mail

Bridging the Gap Between Making Money and Actually Building Wealth

STOCKHOLM, Sweden, June 25, 2026 – AnaCardio, a clinical stage biopharmaceutical company developing novel drugs to treat heart failure, today announced the publication in The Lancet of results from its Phase 1b/2a GOAL-HF1 study evaluating AC01, a first-in-class, oral calcium-sensitising contractile agent, in patients with heart failure with reduced ejection fraction (HFrEF). The results showed a favourable safety and tolerability profile, dose-proportional pharmacokinetics with confirmed target engagement. In exploratory efficacy analyses, numerical rapid and sustained improvements in haemodynamics and cardiac structure and function were observed on top of optimised guideline-directed medical therapy (GDMT).

All amounts presented in this release are in U.S. Dollar (“USD”) unless otherwise stated.

NEW YORK and TORONTO, June 24, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (the “Company” or “Helus Pharma”), a clinical stage pharmaceutical company committed to helping minds heal by developing novel serotonergic agonists (“NSAs”), is pleased to announce the pricing of an underwritten offering of 10,309,280 common shares in the capital of the Company (the “Common Shares”) at an offering price of US$4.85 per Common Share, for aggregate gross proceeds of US$50 million (the “Offering”).

Telehealth program combines licensed medical care, insurance coordination, coaching and multiple prescription pathways for eligible patients

Telehealth company introduces an insurance-first weight-management pathway designed to help eligible patients navigate Zepbound coverage, prior authorization and ongoing virtual care

From 1 July 2026 Vaidas Dominauskas will lead Enterprise (B2B) unit at Telia Lietuva, AB (hereinafter “Telia Lietuva” or “the Company”). The manager is returning to the Company – previously he worked in various management positions at Telia Lietuva for more than 14 years, and in 2022–2025 he headed the state-owned company Regitra.